Answers are grounded in this paper and cite their sources.
Antiretroviral therapy (ART) for human immunodeficiency virus (HIV) prevents illness and death from HIV disease and transmission of HIV infection. To encourage global scale-up of ART, the Joint UN Program on HIV/AIDS (UNAIDS) issued the "95-95-95" targets for the HIV "cascade of care." These targets state that by 2030, 95% of individuals living with HIV will know their HIV status, 95% of people with diagnosed HIV infection will receive ART, and 95% of those taking ART will have achieved suppression of the virus.
No takes yet. Share an insight, caveat, or question.
Ehrenkranz et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: